file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
401 | HIGH | 9 | 32 | 369 |
402 | HLA | 9 | 52 | 230 |
403 | HORSE | 9 | 23 | 207 |
404 | HUMANS | 9 | 42 | 279 |
405 | INHIBITS | 9 | 9 | 98 |
406 | INSULIN | 9 | 55 | 388 |
407 | ISOLATION | 9 | 59 | 291 |
408 | LANGERHANS | 9 | 29 | 267 |
409 | LARGE | 9 | 19 | 157 |
410 | LESSONS | 9 | 33 | 405 |
411 | LITERATURE | 9 | 29 | 200 |
412 | LOW | 9 | 6 | 74 |
413 | METHOD | 9 | 8 | 132 |
414 | MOLECULE | 9 | 24 | 185 |
415 | NONHUMAN | 9 | 10 | 141 |
416 | ORGANS | 9 | 29 | 116 |
417 | PANCREATIC | 9 | 64 | 397 |
418 | PANCREATITIS | 9 | 21 | 187 |
419 | PORCINE | 9 | 21 | 583 |
420 | PREDNISOLONE | 9 | 22 | 138 |
421 | PREVENTS | 9 | 6 | 89 |
422 | RAPID | 9 | 13 | 202 |
423 | RENAL-FUNCTION | 9 | 123 | 404 |
424 | RESEARCH | 9 | 6 | 57 |
425 | SEQUENTIAL | 9 | 33 | 239 |
426 | SOLUBLE | 9 | 10 | 76 |
427 | UNRESPONSIVENESS | 9 | 64 | 247 |
428 | UREMIC | 9 | 25 | 522 |
429 | AMPLIFICATION | 8 | 45 | 100 |
430 | ASSAY | 8 | 30 | 160 |
# | Word | Recs | TLCS | TGCS |
431 | ASSOCIATION | 8 | 32 | 136 |
432 | AUTOIMMUNITY | 8 | 12 | 162 |
433 | CAUSES | 8 | 33 | 308 |
434 | CHALLENGES | 8 | 18 | 151 |
435 | CLINIC | 8 | 21 | 150 |
436 | COMPARED | 8 | 60 | 168 |
437 | COMPLEX | 8 | 9 | 91 |
438 | CONSECUTIVE | 8 | 49 | 214 |
439 | CORRELATION | 8 | 41 | 260 |
440 | CYCLOSPORINE-TREATED | 8 | 69 | 538 |
441 | CYTOMETRIC | 8 | 11 | 52 |
442 | DIAGNOSTIC | 8 | 13 | 230 |
443 | DIFFERENTIAL | 8 | 24 | 275 |
444 | DONOR-TYPE | 8 | 18 | 55 |
445 | ENDOTHELIAL | 8 | 28 | 394 |
446 | FETAL | 8 | 34 | 809 |
447 | GENERATION | 8 | 4 | 94 |
448 | GLOMERULONEPHRITIS | 8 | 38 | 263 |
449 | IMMUNOSUPPRESSED | 8 | 12 | 418 |
450 | IMMUNOTHERAPY | 8 | 1 | 173 |
451 | INFECTIONS | 8 | 18 | 317 |
452 | INFECTIOUS | 8 | 43 | 575 |
453 | INHIBITORS | 8 | 3 | 94 |
454 | INTERACTION | 8 | 15 | 328 |
455 | INTERACTIONS | 8 | 27 | 422 |
456 | INTRAVENOUS | 8 | 7 | 97 |
457 | ISLETS | 8 | 29 | 189 |
458 | LESIONS | 8 | 11 | 218 |
459 | LIGANDS | 8 | 93 | 1524 |
460 | LOCAL | 8 | 23 | 364 |
# | Word | Recs | TLCS | TGCS |
461 | LOCALIZATION | 8 | 177 | 240 |
462 | METHODS | 8 | 22 | 130 |
463 | MODIFIED | 8 | 20 | 109 |
464 | MOFETIL | 8 | 13 | 336 |
465 | MONOCLONAL | 8 | 7 | 147 |
466 | MYCOPHENOLATE | 8 | 13 | 336 |
467 | PARADIGM | 8 | 17 | 83 |
468 | PARTIAL | 8 | 10 | 79 |
469 | POST-TRANSPLANT | 8 | 14 | 277 |
470 | POTENT | 8 | 39 | 236 |
471 | RELATION | 8 | 25 | 157 |
472 | RELATIONSHIP | 8 | 32 | 109 |
473 | RENAL-TRANSPLANTS | 8 | 22 | 145 |
474 | SAFETY | 8 | 12 | 213 |
475 | SECONDARY | 8 | 30 | 161 |
476 | SELECTIVE | 8 | 3 | 170 |
477 | STRATEGY | 8 | 22 | 183 |
478 | SYNERGISTIC | 8 | 16 | 231 |
479 | T-CELLS | 8 | 8 | 134 |
480 | THYMOGLOBULIN | 8 | 59 | 376 |
481 | TISSUES | 8 | 95 | 325 |
482 | TRANSFER | 8 | 12 | 182 |
483 | WEANING | 8 | 249 | 653 |
484 | ABO | 7 | 31 | 237 |
485 | ACCEPTED | 7 | 88 | 267 |
486 | ADJUVANT | 7 | 18 | 199 |
487 | ALEMTUZUMAB | 7 | 24 | 203 |
488 | ANTIHUMAN | 7 | 29 | 173 |
489 | ANTILYMPHOBLAST | 7 | 48 | 208 |
490 | ASSAYS | 7 | 54 | 161 |
# | Word | Recs | TLCS | TGCS |
491 | BASIS | 7 | 582 | 659 |
492 | BENEFITS | 7 | 16 | 120 |
493 | BILIARY | 7 | 37 | 401 |
494 | BLOOD-TRANSFUSION | 7 | 6 | 68 |
495 | BODY | 7 | 20 | 572 |
496 | CENTER | 7 | 33 | 418 |
497 | CHAIN-REACTION | 7 | 59 | 115 |
498 | COMPLEMENT | 7 | 6 | 171 |
499 | CONTRIBUTION | 7 | 2 | 83 |
500 | CONTROL | 7 | 23 | 238 |
501 | CORTICOSTEROIDS | 7 | 4 | 46 |
502 | CULTURE | 7 | 7 | 66 |
503 | CYCLOSPORIN-INDUCED | 7 | 13 | 124 |
504 | CYTOMEGALOVIRUS | 7 | 10 | 245 |
505 | DAMAGE | 7 | 5 | 70 |
506 | DELAYED | 7 | 51 | 267 |
507 | DOSAGE | 7 | 24 | 240 |
508 | DOSES | 7 | 12 | 114 |
509 | DUCT | 7 | 33 | 229 |
510 | FINDINGS | 7 | 8 | 36 |
511 | FREQUENCY | 7 | 16 | 228 |
512 | GASTROINTESTINAL | 7 | 15 | 170 |
513 | GRAFT-SURVIVAL | 7 | 41 | 423 |
514 | GRAFT-VS-HOST | 7 | 17 | 90 |
515 | GRAFTING | 7 | 58 | 281 |
516 | HAMSTER-TO-RAT | 7 | 24 | 176 |
517 | HISTORICAL | 7 | 142 | 323 |
518 | HYPERACUTE | 7 | 84 | 722 |
519 | IMMUNOBIOLOGY | 7 | 21 | 3601 |
520 | IMMUNOMODULATORY | 7 | 7 | 108 |
# | Word | Recs | TLCS | TGCS |
521 | IMPROVED | 7 | 14 | 182 |
522 | INCREASES | 7 | 57 | 443 |
523 | INDICATIONS | 7 | 10 | 227 |
524 | INFUSIONS | 7 | 98 | 199 |
525 | INTRAGRAFT | 7 | 32 | 123 |
526 | KIDNEY-TRANSPLANTS | 7 | 17 | 160 |
527 | KILLER | 7 | 20 | 153 |
528 | LEARNED | 7 | 34 | 461 |
529 | LONG | 7 | 54 | 690 |
530 | MARROW-DERIVED | 7 | 74 | 334 |
531 | MATERNAL | 7 | 49 | 1020 |
532 | MEASUREMENT | 7 | 66 | 278 |
533 | MODIFICATION | 7 | 4 | 77 |
534 | MONONUCLEAR | 7 | 11 | 99 |
535 | NEPHRECTOMY | 7 | 8 | 142 |
536 | PATHWAY | 7 | 17 | 267 |
537 | PERIOPERATIVE | 7 | 33 | 164 |
538 | PIGS | 7 | 5 | 52 |
539 | POPULATION | 7 | 16 | 117 |
540 | POSITIVE | 7 | 10 | 192 |
541 | POSTOPERATIVE | 7 | 33 | 150 |
542 | PREPARATIONS | 7 | 14 | 117 |
543 | PRIMATE | 7 | 17 | 129 |
544 | PRODUCED | 7 | 22 | 120 |
545 | PROLONG | 7 | 89 | 478 |
546 | PROPHYLAXIS | 7 | 8 | 206 |
547 | PROTEINS | 7 | 9 | 157 |
548 | PROTOCOLS | 7 | 22 | 94 |
549 | RECOVERY | 7 | 29 | 220 |
550 | REGIMEN | 7 | 46 | 192 |
# | Word | Recs | TLCS | TGCS |
551 | RELEASE | 7 | 21 | 238 |
552 | RISK-FACTORS | 7 | 62 | 627 |
553 | SELECTION | 7 | 29 | 68 |
554 | SHORT-TERM | 7 | 46 | 153 |
555 | STABLE | 7 | 24 | 461 |
556 | TRENDS | 7 | 131 | 242 |
557 | UPDATE | 7 | 10 | 219 |
558 | VARIABLE | 7 | 154 | 275 |
559 | WHOLE-BLOOD | 7 | 27 | 161 |
560 | YEAR | 7 | 20 | 212 |
561 | ABDOMINAL | 6 | 76 | 560 |
562 | ACTIVATED | 6 | 8 | 65 |
563 | ADULTS | 6 | 40 | 158 |
564 | ALLOGENIC | 6 | 3 | 12 |
565 | ALS | 6 | 6 | 34 |
566 | ANTI-HUMAN | 6 | 28 | 158 |
567 | ANTILYMPHOID | 6 | 436 | 480 |
568 | ARTERIAL | 6 | 6 | 159 |
569 | ARTERY | 6 | 14 | 229 |
570 | BILATERAL | 6 | 21 | 161 |
571 | BLOCKADE | 6 | 15 | 218 |
572 | BRONCHIOLITIS | 6 | 3 | 76 |
573 | CAUSE | 6 | 131 | 304 |
574 | CEREBRAL | 6 | 9 | 136 |
575 | CHANGING | 6 | 4 | 49 |
576 | CHEMICAL | 6 | 14 | 134 |
577 | CHIMERAS | 6 | 9 | 76 |
578 | CLINICALLY | 6 | 14 | 220 |
579 | COMPLETE | 6 | 31 | 272 |
580 | CONTENT | 6 | 8 | 38 |
# | Word | Recs | TLCS | TGCS |
581 | CONTROLLED | 6 | 34 | 136 |
582 | CORNEAL | 6 | 6 | 78 |
583 | COURSE | 6 | 21 | 180 |
584 | CULTURED | 6 | 36 | 181 |
585 | CYA | 6 | 22 | 134 |
586 | CYCLOPHOSPHAMIDE | 6 | 36 | 164 |
587 | CYCLOSPORINE-INDUCED | 6 | 19 | 239 |
588 | DATA | 6 | 2 | 65 |
589 | DEPLETION | 6 | 41 | 209 |
590 | DEVELOPING | 6 | 21 | 221 |
591 | DIABETIC | 6 | 1 | 38 |
592 | DYSFUNCTION | 6 | 18 | 134 |
593 | ENHANCED | 6 | 8 | 59 |
594 | EPITHELIAL | 6 | 9 | 303 |
595 | ESTABLISHMENT | 6 | 40 | 83 |
596 | FIRST | 6 | 13 | 148 |
597 | FKBP | 6 | 48 | 829 |
598 | FLUORESCENCE | 6 | 17 | 169 |
599 | GENETIC | 6 | 1 | 68 |
600 | HYPERPLASIA | 6 | 42 | 378 |